Literature DB >> 8325634

Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes.

C V Johnson1, D E Cool, M B Glaccum, N Green, E H Fischer, A Bruskin, D E Hill, J B Lawrence.   

Abstract

This work reports the isolation, partial characterization, and chromosomal mapping of several human T-cell protein tyrosine phosphatase (PTPase) sequences and provides a direct comparison of the specificity of cDNA versus genomic probes in discriminating the location of genes versus pseudogenes by fluorescence in situ hybridization. In initial attempts to map the T-cell (TC) PTP gene using a 2-kb cDNA, several labeled sites were noted, raising the possibility of multiple related sequences within the genome. To address this, four genomic clones were obtained with homology to the TC PTP cDNA and characterized for their primary structure and their position within the human genome. Based on the presence or absence of an open reading frame and the intron/exon structure, two of these clones were found to be overlapping sequences encoding the true TC PTP gene and two were highly related but distinct processed pseudogenes. The TC PTP gene (gene symbol PTPN2) encoded by clones L17-2 and L5-1 localized to chromosome 18p11.2-p11.3, whereas pseudogenes encoded by clone L17-1, entitled TCPS1 (gene symbol PTPN2P1), and clone L18, entitled TCPS13 (gene symbol PTPN2P2), mapped to chromosomes 1q22-q24 and 13q12-q13, respectively. A direct comparison of the specificity of genomic and cDNA probes demonstrated that under identical conditions the genomic probes (containing both exon and intron sequences) readily identified a single specific site of hybridization, whereas the cDNA identified sites of both the gene and its pseudogenes. While providing mapping and sequencing information on the TC PTPase sequences, this work illustrates a strategy for addressing a recurrent problem in gene mapping studies where highly related sequences exist within the genome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325634     DOI: 10.1006/geno.1993.1239

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  Interactions of U2 gene loci and their nuclear transcripts with Cajal (coiled) bodies: evidence for PreU2 within Cajal bodies.

Authors:  K P Smith; J B Lawrence
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

Review 2.  Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

3.  Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer.

Authors:  Chunling Yi; Joseph H McCarty; Scott A Troutman; Matthew S Eckman; Roderick T Bronson; Joseph L Kissil
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

4.  A syndromic form of autosomal recessive congenital microcephaly (Jawad syndrome) maps to chromosome 18p11.22-q11.2.

Authors:  Muhammad Jawad Hassan; Muhammad Salman Chishti; Syed Muhammad Jamal; Muhammad Tariq; Wasim Ahmad
Journal:  Hum Genet       Date:  2007-12-11       Impact factor: 4.132

Review 5.  Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

6.  Nonrandom gene organization: structural arrangements of specific pre-mRNA transcription and splicing with SC-35 domains.

Authors:  Y Xing; C V Johnson; P T Moen; J A McNeil; J Lawrence
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

Review 7.  PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.

Authors:  Jiachun Song; Jinxin Lan; Jiaping Tang; Na Luo
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.